<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02970214</url>
  </required_header>
  <id_info>
    <org_study_id>GANIFU-C-001</org_study_id>
    <nct_id>NCT02970214</nct_id>
  </id_info>
  <brief_title>Follow-up of GANI_MED Cardio Cohorts</brief_title>
  <acronym>GANIFU-Card</acronym>
  <official_title>Greifswald Approach to Individualized Medicine (GANI_MED) - Follow-up of Cardiovascular Cohorts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Follow-up of two hospital-based patient cohorts (heart failure, metabolic comorbidities in
      CVD), recruited at baseline by the GANI_MED-project (Greifswald Approach to Individualized
      Medicine). Standardized protocols will be used for the assessment of medical history,
      laboratory biomarkers, and the collection of various biosamples for bio-banking purposes.
      Comparisons with the general background population will be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5-year follow-up of two hospital-based patient cohorts (heart failure, metabolic
      comorbidities in CVD), recruited at baseline by the GANI_MED-project (Greifswald Approach to
      Individualized Medicine). Subjects will be comprehensively phenotypes using standardized
      protocols for the assessment of medical history, laboratory biomarkers, and the collection of
      various biosamples for bio-banking purposes. A multi-omics based biomarker assessment
      including genome-wide genotyping, transcriptome, metabolome, and proteome analyses
      complements the multi-level approach of GANI_MED. Comparisons with the general background
      population as characterized by the Study of Health in Pomerania (SHIP) will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Cardiovascular events</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>Hospitalization (HF based. all-cause), myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VO2peak</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>Exercise capacity by CPET</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>Quality of life by questionnaire (Minnesota Living with heart failure questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6MW</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>6 minute walk test distance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVEF</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>Left ventricular ejection fraction by echo at time of follow-up</description>
  </secondary_outcome>
  <other_outcome>
    <measure>PWA</measure>
    <time_frame>1-year follow-ups</time_frame>
    <description>pulse wave analysis parameters by Vascular Explorer device (neverdis GmbH, Germany)</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Heart Failure</arm_group_label>
    <description>Patients with chronic heart failure and with/without reduced left ventricular ejection fraction (EF) at baseline (HFrEF, HFmrEF, HFpEF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiometabolic risk</arm_group_label>
    <description>Patients with cardiovascular diseases and metabolic risk factors at baseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention, only observational</intervention_name>
    <description>no intervention, only observational</description>
    <arm_group_label>Heart Failure</arm_group_label>
    <arm_group_label>Cardiometabolic risk</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients included into the baseline examinations of the two cohorts
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation in baseline examination of GANI_MED cohorts (heart failure, metabolic
             risk)

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcus Dörr, MD</last_name>
    <phone>+49383486</phone>
    <phone_ext>80500</phone_ext>
    <email>mdoerr@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephan B Felix, MD</last_name>
    <phone>+49383486</phone>
    <phone_ext>80500</phone_ext>
    <email>felix@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Internal Medicine B, University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <state>MV</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Dörr, MD</last_name>
      <phone>+49383486</phone>
      <phone_ext>80500</phone_ext>
      <email>mdoerr@uni-greifswald.de</email>
    </contact>
    <contact_backup>
      <last_name>Stephan B Felix, MD</last_name>
      <phone>+49383486</phone>
      <phone_ext>80500</phone_ext>
      <email>felix@uni-greifswald.de</email>
    </contact_backup>
    <investigator>
      <last_name>Kristin Lehnert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabine Kaczmarek, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Lousie Pedersen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www2.medizin.uni-greifswald.de/gani_med/index.php?id=603&amp;L=1</url>
    <description>Homepage of GANI_MED project</description>
  </link>
  <reference>
    <citation>Grabe HJ, Assel H, Bahls T, Dörr M, Endlich K, Endlich N, Erdmann P, Ewert R, Felix SB, Fiene B, Fischer T, Flessa S, Friedrich N, Gadebusch-Bondio M, Salazar MG, Hammer E, Haring R, Havemann C, Hecker M, Hoffmann W, Holtfreter B, Kacprowski T, Klein K, Kocher T, Kock H, Krafczyk J, Kuhn J, Langanke M, Lendeckel U, Lerch MM, Lieb W, Lorbeer R, Mayerle J, Meissner K, zu Schwabedissen HM, Nauck M, Ott K, Rathmann W, Rettig R, Richardt C, Saljé K, Schminke U, Schulz A, Schwab M, Siegmund W, Stracke S, Suhre K, Ueffing M, Ungerer S, Völker U, Völzke H, Wallaschofski H, Werner V, Zygmunt MT, Kroemer HK. Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J Transl Med. 2014 May 23;12:144. doi: 10.1186/1479-5876-12-144.</citation>
    <PMID>24886498</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2016</study_first_posted>
  <last_update_submitted>November 19, 2016</last_update_submitted>
  <last_update_submitted_qc>November 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>heart disease</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>metabolic risk</keyword>
  <keyword>comorbidities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

